- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03936920
Intra and Inter Reliability and Validity of the Turkish Version of Ottowa Sitting Scale in Intensive Care Unit Survivors
Introduction-Objective: Balance evaluation is one of the most important components of physical examination. Studies on equilibrium assessment in different research groups; It includes measurements that assess the seating balance, which does not require complex measurements or ambulation.
In the literature, there is no clear information about balance effect in intensive care patients who can not be ambulated due to loss of advanced muscle strength, especially in the early period.
Ottowa Sitting Scale is a scale in which the balance is evaluated in the sitting position and it has no validity and reliability in Turkish.
Therefore, the aim of this study is to examine the reliability and validity of the Ottowa Sitting Scale Turkish version between measurements and measurements.
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Cigli
-
İzmir, Cigli, Turkey
- Izmir University of Health Sciences Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Volunteer to participate in the study
- To understand Turkish commands
- To be able to be independent in the previous functional status
- Sleep at least 24 hours in intensive care
Exclusion Criteria:
- Do not want to participate in the study
- Central or peripheral neurological damage
- Don't understand Turkish commands
- Unconsciousness
- Arrhythmia
- Acute myocardial infarction
- Hemodynamic instability (Blood pressure> 200 or <80; Heart rate <40 or> 130, O2 saturation <88%)
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ottowa Sitting Scale
Time Frame: 1 day
|
It is a scale that does not require ambulation, is able to maintain static sitting position in the sitting position, can move in short distance, can move long distance, body rotation ability and ability to move on the hip can be fulfilled.
The scoring of each unit varies between 0-4 and the maximum score is 40.
|
1 day
|
Functional Independence Scale (FIM)
Time Frame: 1 day
|
FIM shows the degree of independence in the basic physical and cognitive activities of the individual in daily life.
FIM consists of 18 questions and mainly measures 2 parameters (1- physical / motor function, 2- cognitive / cognitive function).
Each item is scored at 7 levels (1-7), 'level 1 yardım means full help, and Her level 7 lan means full independence.
FIM total score is between 18-126 points.
The higher the individual's score, the higher the level of independence.
|
1 day
|
Berg Balance Test
Time Frame: 1 day
|
It consists of 14 questions in which it is evaluated whether or not the balance related tasks can be fulfilled in the changing spectrum from sitting position to standing up to one foot.
0: cannot do 4: is scored as doing independently.
The total score is 56.
The risk of a fall from 0 to 20 is high, the risk of a fall from 21 to 40 is considered to be low and the risk of a fall from 41 to 56 is considered low.
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ilknur Gursan, Izmir Katip Celebi University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IzmırIKCU
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functional Disturbance
-
Loma Linda UniversityTerminatedHeart; Functional DisturbanceUnited States
-
Far Eastern Memorial HospitalCompletedHeart; Functional DisturbanceTaiwan
-
Guangdong Provincial People's HospitalUnknownKidney; Functional DisturbanceChina
-
AstraZenecaCompletedHepatic; Functional DisturbanceUnited States
-
Centre Hospitalier Universitaire de BesanconNot yet recruitingAging | Functional Disturbance | Home
-
University of CopenhagenRigshospitalet, Denmark; Glostrup University Hospital, Copenhagen; Agroscope... and other collaboratorsTerminatedHealthy | Ileostomy; Functional DisturbanceDenmark
-
Szeged UniversityActive, not recruitingSurgery | Functional Disturbance | Dopamine | Bronchodilation | HeartHungary
-
University of Sao PauloSamsung ElectronicsCompletedHeart; Surgery, Heart, Functional Disturbance as ResultBrazil
-
Oslo University HospitalUniversity of OsloCompletedHeart; Surgery, Heart, Functional Disturbance as ResultNorway
-
Azienda Ospedaliera Universitaria Integrata VeronaRecruitingHeart; Surgery, Heart, Functional Disturbance as ResultItaly